Action required on falling treatment rates

Australia will not achieve the goal of eradicating hepatitis C without further action to ensure patients are identified and treated.

Speaking with PharmaDispatch following her appointment as president of Hepatitis Australia, Felicity McNeill PSM, said so much positive work has been done, with thousands of people cured, but all stakeholders must come together to address the fact treatment rates are in decline.

Read More

Familiar face to lead Hepatitis Australia Board.

Someone very familiar to the pharmaceutical sector has been appointed president of Hepatitis Australia. Felicity McNeill PSM, who for almost five years served as first assistant secretary of the Pharmaceutical Benefits Division, has been appointed to the part-time role of president of the national peak body focussed on representing Australians living with hepatitis B and C.

Read More

World Hepatitis Summit - Final day highlights

After three days of discussing, debating and formulating solutions together, the World Hepatitis Summit 2017 drew to a close on Friday. Over 900 delegates from 110 countries descended on São Paulo, Brazil all armed with one goal: the elimination of viral hepatitis. At the event, double the size of the inaugural World Hepatitis Summit 2015, important steps were made to reach this goal by 2030.

Read More